laurence.jocaille_120

About laurence.jocaille_120

This author has not yet filled in any details.
So far laurence.jocaille_120 has created 393 blog entries.

Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force

2021-07-29T22:38:03+02:00

L. Biganzoli, M. Aapro, Sibylle Loibl, Hans Wildiers, Etienne Brain. Cancer Treatment Reviews February 2016 Volume 43, Pages 19–26

Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force2021-07-29T22:38:03+02:00

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.

2021-07-29T22:38:03+02:00

Graff JN, Baciarello G, Armstrong AJ, Higano CS, Iversen P, Flaig TW, Forer D, Parli T, Phung D, Tombal B, Beer TM, Sternberg CN. Ann Oncol. 2016 Feb;27(2):286-94. doi: 10.1093/annonc/mdv542. Epub 2015 Nov 16.

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.2021-07-29T22:38:03+02:00

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

2021-10-25T15:43:31+02:00

Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff A, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. J Clin Oncol. 2016 Jan 11. pii: JCO626341. (Journal of Clinical Oncology)

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 499072021-10-25T15:43:31+02:00

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

2021-07-29T22:38:03+02:00

Aparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provençal J, Breysacher G, Legoux JL, Lepère C, Charneau J, Cretin J, Chone L, Azzedine A, Bouché O, Sobhani I, Bedenne L, Mitry E; for FFCD investigators. Ann Oncol. 2016 Jan;27(1):121-7. doi: 10.1093/annonc/mdv491. Epub 2015 Oct 20.

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)2021-07-29T22:38:03+02:00

A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators.

2021-07-29T22:38:03+02:00

Kenis C, Heeren P, Decoster L, Van Puyvelde K, Conings G, Cornelis F, Cornette P, Moor R, Luce S, Libert Y, Van Rijswijk R, Jerusalem G, Rasschaert M, Langenaeken C, Baitar A, Specenier P, Geboers K, Vandenborre K, Debruyne PR, Vanoverbeke K, Van den Bulck H, Praet JP, Focan C, Verschaeve V, Nols N, Goeminne JC, Petit B, Lobelle JP, Flamaing J, Milisen K, Wildiers H.   J Nutr Health Aging. 2016;20(1):60-70. doi: 10.1007/s12603-015-0538-4.

A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators.2021-07-29T22:38:03+02:00
Go to Top